Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-08 Cormorant Asset Management, LP 10% owner Purchase +156,597 $45.26 $7.1M 2,016,138
2024-03-08 Cormorant Asset Management, LP 10% owner Purchase +8,862 $45.96 $407K 2,025,000
2024-03-07 Cormorant Asset Management, LP 10% owner Purchase +46,799 $37.82 $1.8M 1,521,799
2024-03-07 Cormorant Asset Management, LP 10% owner Purchase +10,736 $39.13 $420K 1,532,535
2024-03-07 Cormorant Asset Management, LP 10% owner Purchase +90,325 $39.99 $3.6M 1,622,860
2024-03-07 Cormorant Asset Management, LP 10% owner Purchase +102,140 $41.23 $4.2M 1,725,000
2024-02-27 Smethurst Dominic Chief Medical Officer Grant or award +50,000 50,000
2024-02-27 Smethurst Dominic Chief Medical Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2024-02-12 Moran Sean F. Chief Financial Officer Grant or award +40,176 46,818
2024-02-12 Moran Sean F. Chief Financial Officer Grant or award · Stock Option (right to buy) +40,176 40,176
2024-02-12 Cohen Yuval Chief Executive Officer Grant or award +73,947 84,400
2024-02-12 Cohen Yuval Chief Executive Officer Grant or award · Stock Option (right to buy) +73,947 73,947
2024-02-02 Cormorant Asset Management, LP 10% owner Purchase +750,000 $19.00 $14.3M 1,475,000
2024-01-26 HOLMER ALAN F Director Option exercise +629 $4.97 $3K 1,379
2024-01-26 HOLMER ALAN F Director Option exercise · Options to purchase common stock −629 $4.97 $3K 0
2024-01-26 Cohen Yuval Chief Executive Officer Option exercise +7,179 $4.97 $36K 7,179
2024-01-26 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock −7,179 $4.97 $36K 0
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +14,388 $25.73 $370K 456,756
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +15,243 $26.66 $406K 471,999
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +36,747 $27.70 $1.0M 508,746

Page 8 of 10 · 200 trades